ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO460

Development of Risk-Prediction Tool for Peritoneal Dialysis-Associated Peritonitis and External Validation in the PDTAP Cohort

Session Information

  • Home Dialysis - 2
    October 26, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

  • Qiao, Yumeng, Peking University First Hospital, Beijing, Beijing, China
  • Dong, Jie, Peking University First Hospital, Beijing, Beijing, China
Background

Although peritoneal dialysis related peritonitis is a common complication among peritoneal dialysis (PD) patients, there is no validated and recognized tool to predict disease prognosis. This limits patient-specific risk stratification and treatment decisions.

Methods

A single-center peritonitis cohort was used for model derivation and Peritoneal Dialysis Telemedicine-assisted Platform (PDTAP) cohort was used for external validation. Logistic regression models were used to analyze the risk of treatment failure within 1 month of peritonitis, i.e. a composite of peritonitis-related mortality and transferring to hemodialysis. The discrimination and calibration were evaluated using C statistics, Hosmer-Lemeshow (HL) test, Akaike information criterion (AIC), Bayesian information criterion (BIC) and calibration curves. Predictors were weighted to calculate a risk score.

Results

Totally, 528 and 1190 first-episode peritonitis were included in the derivation cohort and validation cohort, respectively. A total point of 5 in basic model was developed including baseline albumin <35g/L and PD duration >25months, and a total point of 29 in extended model was developed including age >60 years old, PD duration >25months, the white cell count >300/mm3 in dialysis effluent on the day 3, and causative organism. Compared with basic model, the extended model performs better with higher C statistic [0.744 (95%CI 0.684-0.804) vs. 0.635 (95%CI 0.574-0.696), P = 0.012], HL statistic [6.73 (8df; P = 0.566) vs. 3.27 (2df; P = 0.195) and lower AIC (389.10 vs. 509.74) and BIC (421.99 vs. 522.50). Both models in the validation cohort performed similar or better discrimination and calibration, as shown in C statistics [0.620 (95% CI 0.579-0.661) in basic model; 0.871 (95%CI 0.837, 0.905) in extended model] and HL statistic [0.31 (2df; P = 0.858) in basic model; 7.86 (8df; P = 0.447) in extended model].

Conclusion

In this study, the basic and extended models for predicting treatment failure of peritonitis were established based on commonly used clinical data, which were applicable to different clinical scenarios and facilitated clinical doctors to identify high-risk individuals and adjust treatment decisions.